CEO SUMMARY: Drug discovery efforts by pharmaceutical companies often need a boost from anatomic pathology practices and clinical laboratories. Forward-thinking lab leaders and pathologists can take advantage of their data and expertise to partner with pharma, setting the stage for new revenue streams. CLINICAL AND PATHOLOGY LABORATORIES COULD OPEN NEW REVENUE STREAMS through partnerships with […]
To access this post, you must purchase The Dark Report.